• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Instinct Bio Technical Company Holdings Inc. - Common stock (NQ:BIOT)

0.3740 +0.0040 (+1.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 535
Open 0.3740
Bid (Size) 0.3900 (1,500)
Ask (Size) 0.4099 (2,200)
Prev. Close 0.3700
Today's Range 0.3740 - 0.3740
52wk Range 0.3601 - 50.00
Shares Outstanding 8,024,092
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Instinct Bio Receives Nasdaq Notifications Regarding Minimum Bid Requirement and Minimum Market Value of Listed Securities and Publicly Held Shares
September 15, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives
September 04, 2026
Follow-up to the Company’s July 29, July 30 and August 10, 2026 announcements 
From Instinct Bio Technical Company Holdings Inc.
Via GlobeNewswire

Performance

YTD
-97.6%
-97.6%
1 Month
-1.4%
-1.4%
3 Month
-97.6%
-97.6%
6 Month
-97.6%
-97.6%
1 Year
-97.6%
-97.6%

More News

Read More
News headline image
Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia
August 10, 2026
From Instinct Bio Technical Company Holdings Inc.
Via GlobeNewswire
News headline image
Instinct Bio Announces Strategic Collaboration With INVITRX to Expand GENREVER Into U.S. and Advance Indonesia Regenerative Medicine Initiatives
July 30, 2026
Via NewMediaWire
News headline image
Blade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology Conference
August 01, 2022
From Blade Therapeutics, Inc.
Via Business Wire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
June 03, 2022
Via InvestorPlace
News headline image
Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference
May 18, 2022
From Blade Therapeutics, Inc.
Via Business Wire
News headline image
Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference
May 16, 2022
From Blade Therapeutics, Inc.
Via Business Wire
News headline image
Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package
April 04, 2022
From Blade Therapeutics, Inc.
Via Business Wire
News headline image
Blade Therapeutics to Present Data from Preclinical and Phase 1 Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference
March 24, 2022
From Blade Therapeutics, Inc.
Via Business Wire
News headline image
Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary Fibrosis
January 12, 2022
From Blade Therapeutics, Inc.
Via Business Wire

Frequently Asked Questions

Is Instinct Bio Technical Company Holdings Inc. - Common stock publicly traded?
Yes, Instinct Bio Technical Company Holdings Inc. - Common stock is publicly traded.
What exchange does Instinct Bio Technical Company Holdings Inc. - Common stock trade on?
Instinct Bio Technical Company Holdings Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Instinct Bio Technical Company Holdings Inc. - Common stock?
The ticker symbol for Instinct Bio Technical Company Holdings Inc. - Common stock is BIOT on the Nasdaq Stock Market
What is the current price of Instinct Bio Technical Company Holdings Inc. - Common stock?
The current price of Instinct Bio Technical Company Holdings Inc. - Common stock is 0.3740
When was Instinct Bio Technical Company Holdings Inc. - Common stock last traded?
The last trade of Instinct Bio Technical Company Holdings Inc. - Common stock was at 09/15/26 04:00 PM ET
What is the market capitalization of Instinct Bio Technical Company Holdings Inc. - Common stock?
The market capitalization of Instinct Bio Technical Company Holdings Inc. - Common stock is 3.00M
How many shares of Instinct Bio Technical Company Holdings Inc. - Common stock are outstanding?
Instinct Bio Technical Company Holdings Inc. - Common stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap